Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday downplayed CVS Health (NYSE:CVS)’s decision to drop the...
By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday downplayed CVS Health (NYSE:CVS)’s decision to drop the...
By Allison Lampert and Utkarsh Shetti (Reuters) -Howmet Aerospace raised its 2025 profit forecast on Thursday, despite impacts...
By David Shepardson WASHINGTON (Reuters) -The U.S House of Representatives voted Thursday to bar California’s landmark plan to...
By Steve Holland, Erin Banco and Gram Slattery WASHINGTON (Reuters) -U.S. President Donald Trump’s national security adviser Mike...
– U.K. stocks were higher after the close on Thursday, as gains in the Travel & Leisure, Automobiles & Parts and...
(This April 30 story has been corrected to remove references to Cerebrus Capital Management and Cantor Fitzgerald, in paragraph...
By Nate Raymond WASHINGTON (Reuters) -President Donald Trump’s administration has sued Hawaii and Michigan to try to stop them...
By Jody Godoy and Mike Stone WASHINGTON (Reuters) - The U.S. Department of Defense wants new and existing defense contracts to...
-- Shares of Olo Inc (NYSE:OLO) gained 11.6% Thursday following reports from Bloomberg News Wednesday afternoon...
By Mariam Sunny and Christy Santhosh (Reuters) - Biogen (NASDAQ:BIIB) beat first-quarter profit and revenue expectations on...